Recently, a study reported that double Ki-67 and synaptophysin immunolabeling enables a more accurate measurement of the number of proliferating tumor cells compared with a single Ki-67 immunolabeling in pNENs from EUS-FNB specimens [78]. The gene discussed is MKI67; the disease is neoplasm.